📣 VC round data is live. Check it out!
- Public Comps
- EUDA Health
EUDA Health Valuation Multiples
Discover revenue and EBITDA valuation multiples for EUDA Health and similar public comparables like Vanfund Urban Investment, Mach7 Technologies, PharmX Technologies, Mentice and more.
EUDA Health Overview
About EUDA Health
EUDA Health Holdings Ltd is a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia, and China. It offers inventive, accessible, and science-based health solutions to support the shift in regional healthcare from reactive medical treatment to proactive, longevity-focused care. The group also runs a Singapore-based property management business. It operates in two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include management and security services for properties such as condominiums, residential apartments, business office buildings, and shopping malls.
Founded
2021
HQ

Employees
99
Website
Financials (FY)
EV
$44M
Valuation Multiples
Start free trialEUDA Health Financials
EUDA Health reported last fiscal year revenue of $7M and negative EBITDA of ($2M).
In the same fiscal year, EUDA Health generated $3M in gross profit, ($2M) in EBITDA losses, and had net loss of ($3M).
EUDA Health P&L
In the most recent fiscal year, EUDA Health reported revenue of $7M and EBITDA of ($2M).
EUDA Health is unprofitable as of last fiscal year, with gross margin of 44%, EBITDA margin of (31%), and net margin of (41%).
Financial data powered by Morningstar, Inc.
EUDA Health Stock Performance
EUDA Health has current market cap of $42M, and enterprise value of $44M.
Market Cap Evolution
EUDA Health's stock price is $16.94.
EUDA Health share price increased by 16.6% in the last 30 days, and by 364.1% in the last year.
EUDA Health has an EPS (earnings per share) of $-1.11.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $44M | $42M | 10.9% | 16.6% | -13.1% | 364.1% | $-1.11 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEUDA Health Valuation Multiples
EUDA Health trades at 6.5x EV/Revenue multiple, and (21.2x) EV/EBITDA.
EUDA Health Financial Valuation Multiples
As of May 5, 2026, EUDA Health has market cap of $42M and EV of $44M.
EUDA Health has a P/E ratio of (15.2x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified EUDA Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


EUDA Health Margins & Growth Rates
In the most recent fiscal year, EUDA Health reported gross margin of 44%, EBITDA margin of (31%), and net margin of (41%).
EUDA Health Margins
EUDA Health Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
EUDA Health Operational KPIs
EUDA Health's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
EUDA Health Competitors
EUDA Health competitors include Vanfund Urban Investment, Mach7 Technologies, PharmX Technologies, Mentice, Doctor Care Anywhere, Maps, Data Horizon, MeVis, Carelabs and Healixa.
Most EUDA Health public comparables operate across Telemedicine & Virtual Care, Healthcare Software, B2B SaaS, Vertical SaaS and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.3x | — | (6.0x) | — | |||
| 1.9x | 1.6x | (27.1x) | (20.8x) | |||
| 7.2x | — | 38.1x | — | |||
| 1.2x | 1.2x | 80.4x | 24.5x | |||
| 0.8x | 0.7x | 6.8x | 7.0x | |||
| 1.3x | 1.0x | 4.7x | 5.3x | |||
| 2.2x | — | (3.6x) | — | |||
| 2.2x | — | 10.5x | — | |||
This data is available for Pro users. Sign up to see all EUDA Health competitors and their valuation data. Start Free Trial | ||||||
EUDA Health M&A Activity
EUDA Health has acquired 2 companies to date.
Last acquisition by EUDA Health was on August 28th 2025. EUDA Health acquired Chemokine for undisclosed valuation.
Latest Acquisitions by EUDA Health
| Description | Chemokine is a developer of immune health supplements featuring molecular compounds and gene-modulating formulations. Based in the United States, it produces targeted products that enhance innate immunity through proprietary blends of nucleotides, peptides, and nutraceuticals designed for daily wellness and therapeutic support in viral defense and inflammation management. | — |
| HQ Country | — | |
| HQ City | Singapore | — |
| Deal Date | 28 Aug 2025 | 6 May 2024 |
| Valuation | undisclosed | $15M |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all EUDA Health acquisitions and their M&A valuation multiples. Start Free Trial | ||
EUDA Health Investment Activity
EUDA Health has invested in 1 company to date.
Latest investment by EUDA Health was on January 13th 2026. EUDA Health invested in Shenzhen Inno in their Undisclosed stage round.
Latest Investments by EUDA Health
| Description | Shenzhen Inno is a Shenzhen-based R&D firm specializing in tumor biomarkers and immunotherapy technologies. |
| HQ Country | |
| HQ City | — |
| Deal Date | 13 Jan 2026 |
| Round | Undisclosed stage |
| Raised | undisclosed |
| Investors | EUDA Health |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all EUDA Health investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout EUDA Health
| When was EUDA Health founded? | EUDA Health was founded in 2021. |
| Where is EUDA Health headquartered? | EUDA Health is headquartered in Singapore. |
| How many employees does EUDA Health have? | As of today, EUDA Health has over 99 employees. |
| Who is the CEO of EUDA Health? | EUDA Health's CEO is Alfred Lim. |
| Is EUDA Health publicly listed? | Yes, EUDA Health is a public company listed on Nasdaq. |
| What is the stock symbol of EUDA Health? | EUDA Health trades under EUDA ticker. |
| When did EUDA Health go public? | EUDA Health went public in 2022. |
| Who are competitors of EUDA Health? | EUDA Health main competitors include Vanfund Urban Investment, Mach7 Technologies, PharmX Technologies, Mentice, Doctor Care Anywhere, Maps, Data Horizon, MeVis, Carelabs, Healixa. |
| What is the current market cap of EUDA Health? | EUDA Health's current market cap is $42M. |
| What is the current revenue of EUDA Health? | EUDA Health's last fiscal year revenue is $7M. |
| What is the current EV/Revenue multiple of EUDA Health? | Current revenue multiple of EUDA Health is 6.5x. |
| Is EUDA Health profitable? | No, EUDA Health is not profitable. |
| How many companies EUDA Health has acquired to date? | As of May 2026, EUDA Health has acquired 2 companies. |
| What was the largest acquisition by EUDA Health? | $15M acquisition of CK Health Plus on 6th May 2024 was the largest M&A EUDA Health has done to date. |
| What companies EUDA Health acquired? | EUDA Health acquired CK Health Plus and Chemokine. |
| In how many companies EUDA Health has invested to date? | As of May 2026, EUDA Health has invested in 1 company. |
| What was the last EUDA Health investment? | On 13th January 2026 EUDA Health invested in Shenzhen Inno, participating in a Undisclosed stage round. |
| In what companies EUDA Health invested in? | EUDA Health invested in Shenzhen Inno. |
See public comps similar to EUDA Health
Lists including EUDA Health
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

